General Information of This Antigen (ID: TAR0NGRBV)
Antigen Name
Leucine-rich alpha-2-glycoprotein (LRG1)
Gene Name
LRG1
Gene ID
116844
Synonym
LRG
Sequence
MSSWSRQRPKSPGGIQPHVSRTLFLLLLLAASAWGVTLSPKDCQVFRSDHGSSISCQPPA
EIPGYLPADTVHLAVEFFNLTHLPANLLQGASKLQELHLSSNGLESLSPEFLRPVPQLRV
LDLTRNALTGLPPGLFQASATLDTLVLKENQLEVLEVSWLHGLKALGHLDLSGNRLRKLP
PGLLANFTLLRTLDLGENQLETLPPDLLRGPLQLERLHLEGNKLQVLGKDLLLPQPDLRY
LFLNGNKLARVAAGAFQGLRQLDMLDLSNNSLASVPEGLWASLGQPNWDMRDGFDISGNP
WICDQNLSDLYRWLQAQKDKMFSQNDTRCAGPEAVKGQTLLAVAKSQ

    Click to Show/Hide
Uniprot Entry
A2GL_HUMAN
HGNC ID
HGNC:29480
KEGG ID
hsa:116844
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Magacizumab
ADC Name Payload Target Linker ADC Info
LRG1-ADC 5 [1]
Monomethyl auristatin E
Microtubule (MT)
Dipeptide-diBrPD (dibromopyridazinedione )
Magacizumab PD-MMAE ADC 5 [1]
Monomethyl auristatin E
Microtubule (MT)
Mepstra-PD-PEG3-Mal-Cit-PABC
References
Ref 1 Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target. RSC Chem Biol. 2021 May 31;2(4):1206-1220.